A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide

Molecular Immunology

Volumn 47, Issue 11-12, 2010, Pages 2015-2021

  Leng, Chih Hsiang ^a   Chen, Hsin Wei ^a,b   Chang, Li Sheng ^a   Liu, Hsueh Hung ^a   Liu, Hsin Yu ^a   Sher, Yuh Pyng ^b   Chang, Yu Wen ^a   Lien, Shu Pei ^a   Huang, Tzu Yi ^a   Chen, Mei Yu ^a   Chou, Ai Hsiang ^a   Chong, Pele ^a   Liu, Shih Jen ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adjuvants; Innate immunity; Lipoprotein; Toll like receptors

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23; INTERLEUKIN 27; LIPOPEPTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RECOMBINANT LIPOPROTEIN; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL STRAIN HEK293; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHEMOKINES; CYTOKINES; GENE EXPRESSION PROFILING; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NF-KAPPA B; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

DENGUE VIRUS; MUS;

EID: 77953615581     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.04.012     Document Type: Article

References (34)

1. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R.T., Medzhitov R., Fikrig E., Flavell R.A. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 2002, 8:878-884.
2. Allavena P., Sica A., Vecchi A., Locati M., Sozzani S., Mantovani A. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 2000, 177:141-149.
3. Apte R.N., Voronov E. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?. Immunol. Rev. 2008, 222:222-241.
4. Bechetoille N., Andre V., Valladeau J., Perrier E., Dezutter-Dambuyant C. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. J. Leukoc. Biol. 2006, 80:45-58.
5. BenMohamed L., Gras-Masse H., Tartar A., Daubersies P., Brahimi K., Bossus M., Thomas A., Druilhe P. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol. 1997, 27:1242-1253.
6. Buwitt-Beckmann U., Heine H., Wiesmuller K.-H., Jung G., Brock R., Akira S., Ulmer A.J. TLR1-and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 2006, 281:9049-9057.
7. Chen H.-W., Liu S.-J., Liu H.-H., Kwok Y., Lin C.-L., Lin L.-H., Chen M.-Y., Tsai J.-P., Chang L.-S., Chiu F.-F., Lai L.-w., Lian W.-C., Yang C.-Y., Hsieh S.-Y., Chong P., Leng C.-H. A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design. Vaccine 2009, 27:1400-1409.
8. Cote-Sierra J., Bredan A., Toldos C.M., Stijlemans B., Brys L., Cornelis P., Segovia M., de Baetselier P., Revets H. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect. Immun. 2002, 70:240-248.
9. Cote-Sierra J., Jongert E., Bredan A., Gautam D.C., Parkhouse M., Cornelis P., De Baetselier P., Revets H. A new membrane-bound OprI lipoprotein expression vector: high production of heterologous fusion proteins in Gram (-) bacteria and the implications for oral vaccination. Gene 1998, 221:25-34.
10. Farhat K., Riekenberg S., Heine H., Debarry J., Lang R., Mages J., Buwitt-Beckmann U., Roschmann K., Jung G., Wiesmuller K.-H., Ulmer A.J. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 2008, 83:692-701.
11. Giambartolomei G.H., Zwerdling A., Cassataro J., Bruno L., Fossati C.A., Philipp M.T. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J. Immunol. 2004, 173:4635-4642.
12. Goriely S., Neurath M.F., Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 2008, 8:81-86.
13. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., Kirikae T., Gotz F. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 2006, 177:3162-3169.
14. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 2005, 5:521-531.
15. Infante-Duarte C., Horton H.F., Byrne M.C., Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 2000, 165:6107-6115.
16. Infante-Duarte C., Kamradt T. Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice. Infect. Immun. 1997, 65:4094-4099.
17. Into T., Dohkan J.-I., Inomata M., Nakashima M., Shibata K.-i., Matsushita K. Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae. Infect. Immun. 2007, 75:2253-2259.
18. Khan S., Weterings J.J., Britten C.M., de Jong A.R., Graafland D., Melief C.J.M., van der Burg S.H., van der Marel G., Overkleeft H.S., Filippov D.V., Ossendorp F. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. Mol. Immunol. 2009, 46:1084-1091.
19. Kiura K., Kataoka H., Yasuda M., Inoue N., Shibata K. The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses. FEMS Immunol. Med. Microbiol. 2006, 48:44-55.
20. Leng C.-H., Liu S.-J., Tsai J.-P., Li Y.-S., Chen M.-Y., Liu H.-H., Lien S.-P., Yueh A., Hsiao K.-N., Lai L.-W., Liu F.-C., Chong P., Chen H.-W. A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity. Microb. Infect. 2009, 11:288-295.
21. Liu S.-J., Tsai J.-P., Shen C.-R., Sher Y.-P., Hsieh C.-L., Yeh Y.-C., Chou A.-H., Chang S.-R., Hsiao K.-N., Yu F.-W., Chen H.-W. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-{beta} and interleukin-6. J. Leukoc. Biol. 2007, 82:354-360.
22. Massari P., Visintin A., Gunawardana J., Halmen K.A., King C.A., Golenbock D.T., Wetzler L.M. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 2006, 176:2373-2380.
23. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., Kastelein R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002, 16:779-790.
24. Revets H., Pynaert G., Grooten J., De Baetselier P. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J. Immunol. 2005, 174:1097-1103.
25. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
26. Shimizu T., Kida Y., Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-{kappa}B through TLR1, TLR2, and TLR6. J. Immunol. 2005, 175:4641-4646.
27. Shimizu T., Kida Y., Kuwano K. A triacylated lipoprotein from Mycoplasma genitalium activates NF-{kappa}B through toll-like receptor 1 (TLR1) and TLR2. Infect. Immun. 2008, 76:3672-3678.
28. Smits H., Beelen A.V., Hessle C., Westland R., Jong E.D., Soeteman E., Wold A., Wierenga E., Kapsenberg M. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur. J. Immunol. 2004, 34:1371-1380.
29. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
30. Tawaratsumida K., Furuyashiki M., Katsumoto M., Fujimoto Y., Fukase K., Suda Y., Hashimoto M. Characterization of N-terminal structure of TLR2-activating lipoprotein in Staphylococcus aureus. J. Biol. Chem. 2009, 284:9147-9152.
31. Thakran S., Li H., Lavine C.L., Miller M.A., Bina J.E., Bina X.R., Re F. Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer. J. Biol. Chem. 2008, 283:3751-3760.
32. Weaver C.T., Hawrylowicz C.M., Unanue E.R. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:8181-8185.
33. Yoder A., Wang X., Ma Y., Philipp M.T., Heilbrun M., Weis J.H., Kirschning C.J., Wooten R.M., Weis J.J. Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge. Infect. Immun. 2003, 71:3894-3900.
34. Young D.A., Lowe L.D., Booth S.S., Whitters M.J., Nicholson L., Kuchroo V.K., Collins M. IL-4, IL-10, IL-13, and TGF-{beta} from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:3563-3572.